Effects of selenium supplementation on TPOAb and cytokines in acute autoimmune thyroiditis

Thyroid

Volumn 18, Issue 6, 2008, Pages 669-670

  Gärtner, Roland ^a   Duntas, Leonidas H ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Evgenidion Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; LEVOTHYROXINE; SELENIUM; SODIUM SELENITE; THYROID PEROXIDASE ANTIBODY;

ACUTE AUTOIMMUNE THYROIDITIS; AUTOIMMUNE THYROIDITIS; CLINICAL TRIAL; DRUG EFFICACY; HORMONE SUBSTITUTION; HUMAN; LETTER; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; IODIDE PEROXIDASE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TRACE ELEMENTS;

EID: 46349086115     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0001     Document Type: Letter

References (16)

1. Gärtner R, Gasnier BCH, Dietrich JW, Krebs B, Angstwurm MWA 2002 Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87:1687-1691.
2. Duntas LH, Mantzou E, Koutras DA 2003 Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148:389-393.
3. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, Ganotakis ES 2007 Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto's thyroiditis. Thyroid 17:609-612.
4. Moncayo R, Moncayo H, Kapelari K 2005 Nutritional treatment of incipient thyroid autoimmune disease. Influence of selenium supplementation on thyroid function and morphology in children and young adults. Clin Nutr 24:530-531.
5. Turker O, Kumanlioglu K, Karapolat I, Dogan I 2006 Selenium treatment in autoimmune thyroiditis: 9-months follow-up with variable doses. J Endocrinol 190:151-156.
6. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H 2007 The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin EndocrinolMetab 92:1263-1268.
7. Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schoen R, Antoni A, Kletter K, Dudczak R, Willheim M 2008 No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 18:7-12.
8. Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, Kletter K, Dudczak R, Willheim M 2005 Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 63:191-196.
9. Colin IM, Isaac J, Dupret P, Ledant T, D'Hautcourt JL 2004 Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flow cytometric analysis of peripheral lymphocytes. J Biol Regul Homeost Agents 18:72-76.
10. Roura-Mir C, Catálfamo M, Cheng TY, Marqusee E, Besra GS, Jaraquemada D, Moody DB 2005 CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis. J Immunol 174:3773-3780.
11. Nielsen CH, Hegedus L, Rienneck K, Moeller AC, Leslie RG, Bendtzen K 2007 Production of interleukin (IL)-5 and (IL)-10 accompanies T helper cell type 1 (Th-1) cytokine response to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 147:287-295.
12. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC, Prabhu KS 2007 The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282:17964-17973.
13. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G 1994 Supplementation with selenium and human immune cell functions. Biol Trace Elem Res 41:115-127.
14. Faure P, Ramon O, Favier A, Halimi S 2004 Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 34:475-481.
15. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N 2007 Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 167:148-154.
16. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strau R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R 2007 Selenium in Intensive Care (SIC) study: results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:118-126.